Last checked at 19 Aug 2021 14:25
IN BRIEF: Sareum expects annual loss to widen, increases R&D
IN BRIEF: Sareum expects annual loss to widen, increases R&D
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Sareum Share News (SAR)
SAR Share
Price
SAR Share
News
SAR Share
Chat9
SAR Share
Trades
SAR
Live RNS
SAR Share
Charts
SAR Level 2
Console
SAR Live
Share Price
SAR Broker
Ratings
SAR Directors
Deals
SAR Financial
Diary
SAR
Fundamentals
SAR Short
Positions
SAR
Media
Sareum Information
Share Price Information for Sareum (SAR)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
28.50
Bid:
27.00
Ask:
30.00
Change:
0.00 (0.00%)
Spread:
3.00 (11.111%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
26.75
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.19 Aug 2021 07:41
Sareum expects FY losses to widen on higher R&D costs, supply delays
(Sharecast News) - British drugmaker Sareum said on Thursday that it expects to post a widened full-year loss as a result of increased research-and-development expenditure and delays in compound supply.
Read more9 Aug 2021 17:08
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
Read more6 Aug 2021 15:00
Sareum positive on SRA737 outlook after Sierra call
(Sharecast News) - Specialist drug development company Sareum noted on Friday that Sierra Oncology, the licence holder for the novel Chk1 inhibitor 'SRA737', had discussed its newly-announced global in-licensing agreement with AstraZeneca for AZD5153 with investors, which is a novel BRD4 BET inhibitor, to expand its myelofibrosis pipeline.
Read more30 Jul 2021 19:40
TRADING UPDATES: Capita and Custodian REIT agree disposals
TRADING UPDATES: Capita and Custodian REIT agree disposals
Read more30 Jul 2021 11:00
AIM WINNERS & LOSERS: Sareum in patent boost; Airea flags uncertainty
AIM WINNERS & LOSERS: Sareum in patent boost; Airea flags uncertainty
Read more19 Jul 2021 19:13
TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream
TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream
Read more1 Jul 2021 19:26
TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free
TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free
Read more1 Jul 2021 11:18
Sareum releases 'encouraging' results from Covid-19 research
(Sharecast News) - Specialist drug development company Sareum announced "encouraging" top-line results from its UKRI grant-funded Covid-19 research project on Thursday.
Read more15 Jun 2021 20:28
TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland
TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland
Read more1 Jun 2021 17:43
TRADING UPDATES: Breedon buys Micromix; Marlowe acquires Alarm
TRADING UPDATES: Breedon buys Micromix; Marlowe acquires Alarm
Read more1 Jun 2021 11:30
AIM WINNERS & LOSERS: Sound Energy falls on Morocco tax notification
AIM WINNERS & LOSERS: Sound Energy falls on Morocco tax notification
Read more25 May 2021 17:11
TRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise
TRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise
Read more25 May 2021 10:56
Sareum's pre-clinical development of SDC-1801 delayed by Covid-19
(Sharecast News) - Pharmaceutical company Sareum said on Tuesday that Covid-19 has continued to impact the contract research organisations it was working to complete pre-clinical development of its SDC-1801 drug candidate for autoimmune disease.
Read more23 Apr 2021 12:17
Sareum shares rise after improved interim results, research progress
Sareum shares rise after improved interim results, research progress
Read more